van Dyck CH

References (8)

Title : Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial - Lanctot_2023_Am.J.Geriatr.Psychiatry__
Author(s) : Lanctot KL , Rivet L , Tumati S , Perin J , Sankhe K , Vieira D , Mintzer J , Rosenberg PB , Shade D , Lerner AJ , Padala PR , Brawman-Mintzer O , van Dyck CH , Porsteinsson AP , Craft S , Levey AI , Padala KP , Herrmann N
Ref : American Journal of Geriatry & Psychiatry , : , 2023
Abstract :
PubMedSearch : Lanctot_2023_Am.J.Geriatr.Psychiatry__
PubMedID: 37385898

Title : Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease - Isaias_2014_Front.Aging.Neurosci_6_213
Author(s) : Isaias IU , Spiegel J , Brumberg J , Cosgrove KP , Marotta G , Oishi N , Higuchi T , Kusters S , Schiller M , Dillmann U , van Dyck CH , Buck A , Herrmann K , Schloegl S , Volkmann J , Lassmann M , Fassbender K , Lorenz R , Samnick S
Ref : Front Aging Neurosci , 6 :213 , 2014
Abstract :
PubMedSearch : Isaias_2014_Front.Aging.Neurosci_6_213
PubMedID: 25177294

Title : A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease - van Dyck_2007_Alzheimer.Dis.Assoc.Disord_21_136
Author(s) : van Dyck CH , Tariot PN , Meyers B , Malca Resnick E
Ref : Alzheimer Disease & Associated Disorders , 21 :136 , 2007
Abstract :
PubMedSearch : van Dyck_2007_Alzheimer.Dis.Assoc.Disord_21_136
PubMedID: 17545739

Title : Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers - Staley_2006_J.Neurosci_26_8707
Author(s) : Staley JK , Krishnan-Sarin S , Cosgrove KP , Krantzler E , Frohlich E , Perry E , Dubin JA , Estok K , Brenner E , Baldwin RM , Tamagnan GD , Seibyl JP , Jatlow P , Picciotto MR , London ED , O'Malley S , van Dyck CH
Ref : Journal of Neuroscience , 26 :8707 , 2006
Abstract :
PubMedSearch : Staley_2006_J.Neurosci_26_8707
PubMedID: 16928859

Title : A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil - van Dyck_2006_Am.J.Geriatr.Psychiatry_14_428
Author(s) : van Dyck CH , Schmitt FA , Olin JT
Ref : American Journal of Geriatry & Psychiatry , 14 :428 , 2006
Abstract :
PubMedSearch : van Dyck_2006_Am.J.Geriatr.Psychiatry_14_428
PubMedID: 16670247

Title : Understanding the latest advances in pharmacologic interventions for Alzheimer's disease - van Dyck_2004_CNS.Spectr_9_24
Author(s) : van Dyck CH
Ref : CNS Spectr , 9 :24 , 2004
Abstract :
PubMedSearch : van Dyck_2004_CNS.Spectr_9_24
PubMedID: 15241297

Title : Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET - Fujita_2003_Eur.J.Nucl.Med.Mol.Imaging_30_1620
Author(s) : Fujita M , Ichise M , van Dyck CH , Zoghbi SS , Tamagnan G , Mukhin AG , Bozkurt A , Seneca N , Tipre D , DeNucci CC , Iida H , Vaupel DB , Horti AG , Koren AO , Kimes AS , London ED , Seibyl JP , Baldwin RM , Innis RB
Ref : Eur J Nucl Med Mol Imaging , 30 :1620 , 2003
Abstract :
PubMedSearch : Fujita_2003_Eur.J.Nucl.Med.Mol.Imaging_30_1620
PubMedID: 14523584

Title : Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group - van Dyck_2000_Arch.Gen.Psychiatry_57_157
Author(s) : van Dyck CH , Newhouse PA , Falk WE , Mattes JA
Ref : Arch Gen Psychiatry , 57 :157 , 2000
Abstract :
PubMedSearch : van Dyck_2000_Arch.Gen.Psychiatry_57_157
PubMedID: 10665618